# Evan Kervella

> Evan Kervella is the French engineer, writer and co-founder and CEO of Chipiron, a Paris deeptech company developing a compact ultra-low-field MRI system. After treating his first startup, Shorten, as a formative failure and working in data science, he met physicist Dimitri Labat through Entrepreneur First and began building around SQUID-based sensing, noise cancellation and unconventional reconstruction. Chipiron raised a $17 million Series A in 2025, won VivaTech's 2025 Innovation of the Year award, and reports that its first in-vivo images were produced in December 2025. Kervella was named to Forbes 30 Under 30 Europe in 2022 and publishes essays and videos under the name Ravelkel.

- **Role:** Co-founder and CEO at Chipiron
- **Organizations:** Chipiron, Shorten, AT Internet, METRON, Entrepreneur First, Core Biogenesis
- **Nationality:** French
- **Education:** Engineering degree in mathematics and computer science, Centrale Méditerranée (formerly École Centrale de Marseille), Master of Science in mathematics and computer science, Aix-Marseille University, Master 2 in economics and quantitative finance, University of Bologna, Preparatory studies in mathematics, physics, chemistry and philosophy, Lycée Camille Jullian
- **Known for:** Co-founded Chipiron and led the company through a $17 million Series A announced in April 2025., Named to Forbes 30 Under 30 Europe in Science & Healthcare in 2022., Won France's i-Lab innovation competition for Chipiron in 2022.

## Career timeline

- **2016** — Founded Shorten, an indoor-localization startup for supermarkets, during a gap year.
- **2018** — Completed engineering studies at Centrale Marseille and later described Shorten as a formative failure.
- **2018-2019** — Worked as a data scientist at AT Internet.
- **2019-2020** — Worked as a data scientist at METRON on the company's energy-intelligence platform.
- **2020** — Co-founded Chipiron with physicist Dimitri Labat; French corporate records list Kervella as president from September 2020.
- **2021** — Joined Entrepreneur First's PA4 cohort in Paris and met future co-founder Dimitri Labat on the program's first day, as Kervella later recounted.
- **2022** — Named to Forbes 30 Under 30 Europe in Science & Healthcare and won France's i-Lab innovation competition for Chipiron.
- **2023** — Named Centralien of the Year by the Centrale Marseille alumni community.
- **2024** — Chipiron received France 2030 support, EIC Accelerator backing and France Biotech's Medtech of the Year recognition; Kervella and Labat were included in Le Point's inventors list.
- **2025** — Chipiron closed a $17 million Series A, won VivaTech's Innovation of the Year award and reported its first in-vivo images in December.
- **2026** — Kervella was listed in Le Figaro's Leaders of Tomorrow and Institut Choiseul's Choiseul 100; Chipiron published a roadmap targeting design verification in November 2026.

## Achievements

- Co-founded Chipiron and led the company through a $17 million Series A announced in April 2025.
- Named to Forbes 30 Under 30 Europe in Science & Healthcare in 2022.
- Won France's i-Lab innovation competition for Chipiron in 2022.
- Named Centralien of the Year in 2023.
- Included with Dimitri Labat in Le Point's 2024 inventors list.
- Led Chipiron when it won VivaTech's 2025 Innovation of the Year award.
- Chipiron reported its first in-vivo images on its in-house system in December 2025.
- Listed among Le Figaro's Leaders of Tomorrow in 2026 and the Choiseul 100 in 2026.

## Latest updates

- **2026-04** — Listed in the 2026 Choiseul 100 by Institut Choiseul.
- **2026-01** — Listed as a Le Figaro Leader of Tomorrow in the medtech category.
- **2025-12** — Chipiron reports that it produced the first in-vivo images on its full-body in-house system.
- **2025-09** — Appeared on TechCrunch's Equity podcast to discuss rethinking MRI access.
- **2025-06** — Chipiron won VivaTech's 2025 Innovation of the Year award.
- **2025-04** — Chipiron announced a $17 million Series A to complete R&D, build an investigational device and prepare clinical work.

## Links

- Website: https://www.chipiron.co/
- LinkedIn: https://www.linkedin.com/in/evankervella/
- Twitter/X: https://x.com/ravelkel
- YouTube: https://www.youtube.com/@ravelkel
- Instagram: https://www.instagram.com/ravelkel/

---

Profile page: https://yespress.io/evan-kervella
Published by YesPress — https://yespress.io
Last updated: 2026-08-18